Hepatitis E laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hepatitis E}}
{{Hepatitis E}}
{{CMG}}; {{AOEIC}} {{VK}}
{{CMG}}; {{AE}} {{VK}} {{JS}}
 
==Overview==


==Laboratory Findings==
==Laboratory Findings==
Line 14: Line 16:
Hepatitis E should be suspected in outbreaks of waterborne hepatitis occurring in developing countries, especially if the disease is more severe in pregnant women, or if hepatitis A has been excluded. If laboratory tests are not available, epidemiologic evidence can help in establishing a diagnosis.
Hepatitis E should be suspected in outbreaks of waterborne hepatitis occurring in developing countries, especially if the disease is more severe in pregnant women, or if hepatitis A has been excluded. If laboratory tests are not available, epidemiologic evidence can help in establishing a diagnosis.


==Sources==
[http://www.who.int/mediacentre/factsheets/fs280/en/ WHO]
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 23: Line 23:
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Needs overview]]
{{WS}}
{{WS}}
{{WH}}
{{WH}}

Revision as of 11:43, 26 August 2014

Hepatitis E Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatitis E from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis E laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis E laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis E laboratory tests

CDC on Hepatitis E laboratory tests

Hepatitis E laboratory tests in the news

Blogs on Hepatitis E laboratory tests

Directions to Hospitals Treating Hepatitis E

Risk calculators and risk factors for Hepatitis E laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2] João André Alves Silva, M.D. [3]

Overview

Laboratory Findings

The following tests are done to identify and monitor liver damage from hepatitis B:

  • Albumin level
  • Liver function tests
  • Prothrombin time
  • Antibody test

Since cases of hepatitis E are not clinically distinguishable from other types of acute viral hepatitis, diagnosis is made by blood tests which detect elevated antibody levels of specific antibodies to hepatitis E in the body or by reverse transcriptase polymerase chain reaction (RT-PCR). Unfortunately, such tests are not widely available.

Hepatitis E should be suspected in outbreaks of waterborne hepatitis occurring in developing countries, especially if the disease is more severe in pregnant women, or if hepatitis A has been excluded. If laboratory tests are not available, epidemiologic evidence can help in establishing a diagnosis.

References

Template:WS Template:WH